(AHR) American Healthcare REIT - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock •

AHR: Buildings, Housing, Facilities, Properties, Estates, Healthcare

American Healthcare REIT, Inc. (NYSE:AHR) is a self-managed real estate investment trust that offers investors a unique opportunity to tap into the growing demand for healthcare facilities. By focusing on a diversified portfolio of clinical healthcare properties, including outpatient medical buildings, senior housing, and skilled nursing facilities, AHR positions itself to capitalize on demographic trends such as an aging population and the increasing shift towards outpatient care. This strategic focus allows the company to maintain stable cash flows, a critical factor for REIT investors seeking predictable income.

The companys portfolio is thoughtfully diversified across various healthcare assets, reducing reliance on any single sector. This diversification is particularly advantageous for risk management, as different facilities respond to different market drivers. For instance, senior housing demand is closely tied to demographic changes, while outpatient centers are influenced by healthcare utilization patterns. Such a balanced approach can mitigate risks associated with market fluctuations in individual sectors.

From a financial standpoint, AHRs market capitalization of approximately $4.48 billion underscores its significant presence in the healthcare REIT sector. The price-to-book (P/B) ratio of 2.03 and price-to-sales (P/S) ratio of 2.24 provide insights into the companys valuation. The P/B ratio suggests that investors are valuing the companys assets at twice their book value, indicating confidence in the asset quality. The P/S ratio, meanwhile, reflects the premium investors are placing on the companys revenue generation capabilities, which is crucial for assessing its growth potential.

Geographic diversification is another key strength, with properties spanning 36 states in the U.S., as well as international locations in the UK and Isle of Man. This broad reach helps mitigate regional risks, such as local economic downturns or regulatory changes, enhancing the overall stability of the investment. For investors seeking exposure to healthcare real estate with minimized geographic risk, this diversification

Additional Sources for AHR Stock

AHR Stock Overview

Market Cap in USD 4,702m
Sector Real Estate
Industry REIT - Healthcare Facilities
GiC Sub-Industry Health Care REITs
IPO / Inception 2024-02-07

AHR Stock Ratings

Growth 5y 52.8%
Fundamental 10.7%
Dividend 24.9%
Rel. Strength 101
Analysts 4.25/5
Fair Price Momentum 33.71 USD
Fair Price DCF 12.34 USD

AHR Dividends

Dividend Yield 12m 3.62%
Yield on Cost 5y 8.05%
Annual Growth 5y -50.00%
Payout Consistency 100.0%

AHR Growth Ratios

Growth Correlation 3m 70.1%
Growth Correlation 12m 97.4%
Growth Correlation 5y 97.7%
CAGR 5y 119.80%
CAGR/Max DD 5y 10.10
Sharpe Ratio 12m 3.74
Alpha 121.20
Beta 0.806
Volatility 28.58%
Current Volume 2157.6k
Average Volume 20d 2011.5k
What is the price of AHR stocks?
As of April 03, 2025, the stock is trading at USD 30.79 with a total of 2,157,643 shares traded.
Over the past week, the price has changed by +4.04%, over one month by +1.99%, over three months by +11.87% and over the past year by +128.17%.
Is American Healthcare REIT a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, American Healthcare REIT is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.71 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AHR as of April 2025 is 33.71. This means that AHR is currently overvalued and has a potential downside of 9.48%.
Is AHR a buy, sell or hold?
American Healthcare REIT has received a consensus analysts rating of 4.25. Therefor, it is recommend to buy AHR.
  • Strong Buy: 3
  • Buy: 4
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for AHR stock price target?
According to ValueRays Forecast Model, AHR American Healthcare REIT will be worth about 37.1 in April 2026. The stock is currently trading at 30.79. This means that the stock has a potential upside of +20.33%.
Issuer Forecast Upside
Wallstreet Target Price 33.9 10%
Analysts Target Price 31.1 1.1%
ValueRay Target Price 37.1 20.3%